Several years later, another study confirmed the upregulation of Galectin-3 and LGALS3BP at both RNA and protein level in GBM tissues and were associated with shorter overall survival in GBM patients, in particular in the pro-neural subtype [65]. The gene discussed is LGALS3; the disease is glioblastoma.